Latest News
Lymphoma Research Foundation Funds 28 New Grants Supporting the Next Generation of Lymphoma Scientists
New York, NY (May 20, 2024) – The Lymphoma Research Foundation (LRF), the nation’s largest nonprofit organization devoted to funding innovative lymphoma research and serving the lymphoma community, has awarded 28 new research grants in 2024, amounting to $3.5M to cancer researchers who will advance our understanding of lymphoma and lay the foundation for improved patient care.
The 2024 LRF grantee class encompasses 18 medical and academic institutions, with research initiatives investigating several lymphoma subtypes, genetic mechanisms, and emerging therapeutic methods. The grant selection process is led by LRF’s Scientific Advisory Board (SAB), which is made up of 45 international lymphoma experts dedicated to seeking out the most innovative and promising lymphoma research projects for investment.
“These scientists help to advance our understanding of lymphoma, laying the foundation for improved patient care,” said Ann LaCasce, MD Chair of the LRF Scientific Advisory Board. “The funding given by LRF has a profound impact on these researchers’ careers and enables them to dedicate their careers to studying lymphoma.”
Since its inception, LRF has made major contributions to the lymphoma research enterprise, awarding more than 500 research grants totaling more than $80 million.
“We are pleased to announce this year’s investment in early career lymphoma investigators,” said Meghan Gutierrez, Chief Executive Officer at the Lymphoma Research Foundation. “Through LRF’s unique commitment to these investigators, we are ensuring that the brightest minds in oncology remain committed to the study of lymphoma for the benefit of lymphoma patients everywhere.”
2024 LRF Grant Recipients
Clinical Investigator Career Development Award (CDA)
Tomohiro Aoki, MD, PhD – University Health Network
Preteesh Jain, MD, PhD – University of Texas M.D. Anderson Cancer Center
Niloufer Khan, MD – City of Hope Comprehensive Cancer Center
Christine Ryan, MD – Dana-Farber Cancer Institute
Harsh Shah, DO – The University of Utah
Timothy Vorhees, MD – The Ohio State University College of Medicine
Yucai Wang, MD – Mayo Clinic, Rochester
Samuel Yamshon, MD – Weill Medical College of Cornell University
Postdoctoral Fellowship Grant
Ruth Alonso Alonso, PhD – The Trustees of Columbia University in the City of New York (Dr. Oliver Press Memorial Fellow)
Gonzalo Blanco Ares, PhD – The Feinstein Institutes for Medical Research
Alberto Carturan, MD – The University of Pennsylvania (Jamie Peykoff Follicular Lymphoma Fellow)
Atish Kizhakeyil, PhD – University of Texas M.D. Anderson Cancer Center
Benedikt Pelzer, MD – Weill Medical College of Cornell University (The Levine Family Fellowship)
Michael Schneider, MD, PhD – The Trustees of the University of Pennsylvania
Vignesh Shanmugam, MD – Brigham and Women’s Hospital, Inc. (Condon Family Fellowship)
Moah Sohn, DVM, PhD – Icahn School of Medicine at Mount Sinai (Jamie Peykoff Follicular Lymphoma Fellow)
Lymphoma Clinical Research Mentoring Program
Adam DuVall, MD, MPH – The University of Chicago (Chike Springer Foundation Scholar)
Jordan Goldstein, MD – The Board of Trustees of the Leland Stanford Junior University (Errol M. Cook Memorial Scholar)
Mwanasha Merrill, MD – Dana-Farber Cancer Institute
Christina Poh, MD – University of Washington (Stephanie A. Gregory Distinguished Scholar)
Lauren Shea, MD – University of Alabama at Birmingham School of Medicine (Kanti R. Rai, MD Clinical Scholar)
Danielle Wallace, MD – Wilmot Cancer Institute (Mindy Camp Fedida Memorial Scholar)
Julie Erika Haydu, MD, PhD – Massachusetts General Hospital (Runge Lymphoma Project Scholar)
Lymphoma Scientific Mentoring Program – Lab/Translational Track (LTRMP)
Caitlin Gribbin, MD, MS – Weill Medical College of Cornell University (Jeff Fellinge Scholar)
David Russler-Germain, MD, PhD – Washington University, School of Medicine
Christoph Weigel, PhD – The Ohio State University
Min Xia, PhD – Weill Medical College of Cornell University
Haopeng Yang, PhD – University of Texas M.D. Anderson Cancer Center